Cureety techcare

DEVICE2 trials

Sponsors

Cureety, UNICANCER

Conditions

Metastatic Triple-Negative Breast CarcinomaNeoplasms

Unknown Phase

Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring Tool

CompletedNCT05653609

CureetyNeoplasms

Start: 2022-11-15End: 2022-12-16Updated: 2023-02-09

Telemonitoring Platform CUREETY TECHCARE vs Standard of Care for mTBNC Patients Initiating a First-line Treatment

RecruitingNCT06505018

UNICANCERMetastatic Triple-Negative Breast Carcinoma

Start: 2024-07-25End: 2028-09-02Target: 472Updated: 2025-09-02

Related Papers

A study to assess the diagnostic performance of a digital remote monitoring tool for patients with cancer: The POSITEA-VA study.

Journal of Clinical Oncology2023-06-011 citations